Global Intrauterine Contraceptive Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Intrauterine Contraceptive Market
An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal. An intrauterine contraceptive device may also be used as an emergency contraception method after unprotected sex. An intrauterine contraceptive device is inserted into the uterus with the help of health care professionals.

Due to the COVID-19 pandemic, the global Intrauterine Contraceptive market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Nonhormonal Intrauterine Contraceptive Devices accounting for % of the Intrauterine Contraceptive global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.

Increasing prevalence of unplanned pregnancies, less side-effects associated with intrauterine contraceptive devices, and implementation of affordable care are some of the key factors driving the growth of the global intrauterine contraceptive device market. In addition, increasing awareness about pregnancy is also driving the growth of the global intrauterine contraceptive device market.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Nonhormonal Intrauterine Contraceptive Devices

Hormonal Intrauterine Contraceptive Devices

Segment by Application

Hospitals

Community Health Care Centers

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Intrauterine Contraceptive market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

DKT International

Melbea AG

Pregna International Limited

Ocon Medical Ltd

SMB Corporation of India

Mona Lisa N.V.

TABLE OF CONTENT

1 Study Coverage
1.1 Intrauterine Contraceptive Product Introduction

1.2 Market by Type

1.2.1 Global Intrauterine Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Nonhormonal Intrauterine Contraceptive Devices

1.2.3 Hormonal Intrauterine Contraceptive Devices

1.3 Market by Application

1.3.1 Global Intrauterine Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Community Health Care Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Intrauterine Contraceptive Sales Estimates and Forecasts 2017-2028

2.2 Global Intrauterine Contraceptive Revenue Estimates and Forecasts 2017-2028

2.3 Global Intrauterine Contraceptive Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Intrauterine Contraceptive Sales by Region

2.4.1 Global Intrauterine Contraceptive Sales by Region (2017-2022)

2.4.2 Global Sales Intrauterine Contraceptive by Region (2023-2028)

2.5 Global Intrauterine Contraceptive Revenue by Region

2.5.1 Global Intrauterine Contraceptive Revenue by Region (2017-2022)

2.5.2 Global Intrauterine Contraceptive Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Intrauterine Contraceptive Sales by Manufacturers

3.1.1 Global Top Intrauterine Contraceptive Manufacturers by Sales (2017-2022)

3.1.2 Global Intrauterine Contraceptive Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intrauterine Contraceptive in 2021

3.2 Global Intrauterine Contraceptive Revenue by Manufacturers

3.2.1 Global Intrauterine Contraceptive Revenue by Manufacturers (2017-2022)

3.2.2 Global Intrauterine Contraceptive Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Intrauterine Contraceptive Revenue in 2021

3.3 Global Intrauterine Contraceptive Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Intrauterine Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Intrauterine Contraceptive Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Intrauterine Contraceptive Sales by Type

4.1.1 Global Intrauterine Contraceptive Historical Sales by Type (2017-2022)

4.1.2 Global Intrauterine Contraceptive Forecasted Sales by Type (2023-2028)

4.1.3 Global Intrauterine Contraceptive Sales Market Share by Type (2017-2028)

4.2 Global Intrauterine Contraceptive Revenue by Type

4.2.1 Global Intrauterine Contraceptive Historical Revenue by Type (2017-2022)

4.2.2 Global Intrauterine Contraceptive Forecasted Revenue by Type (2023-2028)

4.2.3 Global Intrauterine Contraceptive Revenue Market Share by Type (2017-2028)

4.3 Global Intrauterine Contraceptive Price by Type

4.3.1 Global Intrauterine Contraceptive Price by Type (2017-2022)

4.3.2 Global Intrauterine Contraceptive Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Intrauterine Contraceptive Sales by Application

5.1.1 Global Intrauterine Contraceptive Historical Sales by Application (2017-2022)

5.1.2 Global Intrauterine Contraceptive Forecasted Sales by Application (2023-2028)

5.1.3 Global Intrauterine Contraceptive Sales Market Share by Application (2017-2028)

5.2 Global Intrauterine Contraceptive Revenue by Application

5.2.1 Global Intrauterine Contraceptive Historical Revenue by Application (2017-2022)

5.2.2 Global Intrauterine Contraceptive Forecasted Revenue by Application (2023-2028)

5.2.3 Global Intrauterine Contraceptive Revenue Market Share by Application (2017-2028)

5.3 Global Intrauterine Contraceptive Price by Application

5.3.1 Global Intrauterine Contraceptive Price by Application (2017-2022)

5.3.2 Global Intrauterine Contraceptive Price Forecast by Application (2023-2028)

6 North America

6.1 North America Intrauterine Contraceptive Market Size by Type

6.1.1 North America Intrauterine Contraceptive Sales by Type (2017-2028)

6.1.2 North America Intrauterine Contraceptive Revenue by Type (2017-2028)

6.2 North America Intrauterine Contraceptive Market Size by Application

6.2.1 North America Intrauterine Contraceptive Sales by Application (2017-2028)

6.2.2 North America Intrauterine Contraceptive Revenue by Application (2017-2028)

6.3 North America Intrauterine Contraceptive Market Size by Country

6.3.1 North America Intrauterine Contraceptive Sales by Country (2017-2028)

6.3.2 North America Intrauterine Contraceptive Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Intrauterine Contraceptive Market Size by Type

7.1.1 Europe Intrauterine Contraceptive Sales by Type (2017-2028)

7.1.2 Europe Intrauterine Contraceptive Revenue by Type (2017-2028)

7.2 Europe Intrauterine Contraceptive Market Size by Application

7.2.1 Europe Intrauterine Contraceptive Sales by Application (2017-2028)

7.2.2 Europe Intrauterine Contraceptive Revenue by Application (2017-2028)

7.3 Europe Intrauterine Contraceptive Market Size by Country

7.3.1 Europe Intrauterine Contraceptive Sales by Country (2017-2028)

7.3.2 Europe Intrauterine Contraceptive Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Intrauterine Contraceptive Market Size by Type

8.1.1 Asia Pacific Intrauterine Contraceptive Sales by Type (2017-2028)

8.1.2 Asia Pacific Intrauterine Contraceptive Revenue by Type (2017-2028)

8.2 Asia Pacific Intrauterine Contraceptive Market Size by Application

8.2.1 Asia Pacific Intrauterine Contraceptive Sales by Application (2017-2028)

8.2.2 Asia Pacific Intrauterine Contraceptive Revenue by Application (2017-2028)

8.3 Asia Pacific Intrauterine Contraceptive Market Size by Region

8.3.1 Asia Pacific Intrauterine Contraceptive Sales by Region (2017-2028)

8.3.2 Asia Pacific Intrauterine Contraceptive Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Intrauterine Contraceptive Market Size by Type

9.1.1 Latin America Intrauterine Contraceptive Sales by Type (2017-2028)

9.1.2 Latin America Intrauterine Contraceptive Revenue by Type (2017-2028)

9.2 Latin America Intrauterine Contraceptive Market Size by Application

9.2.1 Latin America Intrauterine Contraceptive Sales by Application (2017-2028)

9.2.2 Latin America Intrauterine Contraceptive Revenue by Application (2017-2028)

9.3 Latin America Intrauterine Contraceptive Market Size by Country

9.3.1 Latin America Intrauterine Contraceptive Sales by Country (2017-2028)

9.3.2 Latin America Intrauterine Contraceptive Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Intrauterine Contraceptive Market Size by Type

10.1.1 Middle East and Africa Intrauterine Contraceptive Sales by Type (2017-2028)

10.1.2 Middle East and Africa Intrauterine Contraceptive Revenue by Type (2017-2028)

10.2 Middle East and Africa Intrauterine Contraceptive Market Size by Application

10.2.1 Middle East and Africa Intrauterine Contraceptive Sales by Application (2017-2028)

10.2.2 Middle East and Africa Intrauterine Contraceptive Revenue by Application (2017-2028)

10.3 Middle East and Africa Intrauterine Contraceptive Market Size by Country

10.3.1 Middle East and Africa Intrauterine Contraceptive Sales by Country (2017-2028)

10.3.2 Middle East and Africa Intrauterine Contraceptive Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 DKT International

11.1.1 DKT International Corporation Information

11.1.2 DKT International Overview

11.1.3 DKT International Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 DKT International Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 DKT International Recent Developments

11.2 Melbea AG

11.2.1 Melbea AG Corporation Information

11.2.2 Melbea AG Overview

11.2.3 Melbea AG Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Melbea AG Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Melbea AG Recent Developments

11.3 Pregna International Limited

11.3.1 Pregna International Limited Corporation Information

11.3.2 Pregna International Limited Overview

11.3.3 Pregna International Limited Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Pregna International Limited Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Pregna International Limited Recent Developments

11.4 Ocon Medical Ltd

11.4.1 Ocon Medical Ltd Corporation Information

11.4.2 Ocon Medical Ltd Overview

11.4.3 Ocon Medical Ltd Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Ocon Medical Ltd Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Ocon Medical Ltd Recent Developments

11.5 SMB Corporation of India

11.5.1 SMB Corporation of India Corporation Information

11.5.2 SMB Corporation of India Overview

11.5.3 SMB Corporation of India Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 SMB Corporation of India Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 SMB Corporation of India Recent Developments

11.6 Mona Lisa N.V.

11.6.1 Mona Lisa N.V. Corporation Information

11.6.2 Mona Lisa N.V. Overview

11.6.3 Mona Lisa N.V. Intrauterine Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Mona Lisa N.V. Intrauterine Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Mona Lisa N.V. Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Intrauterine Contraceptive Industry Chain Analysis

12.2 Intrauterine Contraceptive Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Intrauterine Contraceptive Production Mode & Process

12.4 Intrauterine Contraceptive Sales and Marketing

12.4.1 Intrauterine Contraceptive Sales Channels

12.4.2 Intrauterine Contraceptive Distributors

12.5 Intrauterine Contraceptive Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Intrauterine Contraceptive Industry Trends

13.2 Intrauterine Contraceptive Market Drivers

13.3 Intrauterine Contraceptive Market Challenges

13.4 Intrauterine Contraceptive Market Restraints

14 Key Findings in The Global Intrauterine Contraceptive Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Delivery Format : EXCEL/Data Pack

Choose License Type

Checkout Inquiry Sample